文献速递帕金森病与运动障碍

住院项目对住院帕金森病患者用药差错的影响

Effects of an Inpatient Program on Medication Errors in Hospitalized People with Parkinson's Disease
RSS 订阅 · Annals of Neurology · 2026-10-22

研究评估了2023年实施的帕金森病住院项目对住院帕金森病患者用药差错率和出院结局的影响。与2018年实施前回顾性队列相比,2024年1—6月实施后阶段在禁用药物剂量、左旋多巴剂量偏差天数、剂型替换、给药时间偏差、漏服及非家庭出院比例上均有所降低。

要点

  • 实施后阶段禁用药物中位剂量数从2降至1(p=0.015)。
  • 左旋多巴剂量偏差天数从43.1%降至38.3%(p<0.0001)。
  • 非家庭出院比例从44.8%降至38.3%(p=0.038)。

核心结论

  • 实施多学科、主动的住院项目后,住院帕金森病患者的用药差错减少、出院结局改善。

研究设计与样本

  • 研究比较了2024年1—6月实施后阶段与2018年实施前回顾性队列,实施后阶段监测了366例次住院。

主要发现

  • 禁用药物中位剂量数从实施前2(IQR=1–6)降至实施后1(IQR=1–2),p=0.015。
  • 左旋多巴剂量偏差天数从43.1%降至38.3%,p<0.0001。
  • 左旋多巴剂型不当替换从18.6%降至5%,p<0.0001。
  • 给药时间偏差从72.2%降至51.8%,p<0.00001。
  • 漏服从21.5%降至16.8%,p=0.013;非家庭出院从44.8%降至38.3%,p=0.038。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective Hospitalized people with Parkinson's disease (PwP) face increased risks of medication errors and discharge to non-home settings, both of which are associated with adverse outcomes. This study assessed differences in medication error rates and discharge outcomes before and after implementation of a dedicated inpatient program for hospitalized PwP. Methods During 2023, a Parkinson's disease (PD) inpatient program was implemented and refined combining: (1) an electronic health record (EHR) census for identification of hospitalized PwP; (2) inpatient monitoring and alignment of inpatient and outpatient regimens by movement-disorders-trained advanced practitioners; (3) customized EHR alerts and levodopa orders; (4) pharmacist support, and (5) staff education. Medication error rates and clinical outcomes were compared between January and June 2024 (post-implementation phase) and a pre-implementation retrospective cohort from 2018. Results From January to June 2024, 366 post-implementation admissions were monitored. Among those receiving contraindicated medications, the median number of doses decreased from 2 (interquartile range [IQR] = 1–6) during pre-implementation to 1 (IQR: 1–2) post-implementation (p = 0.015). Days with a levodopa dose deviation decreased from 43.1% to 38.3%, p < 0.0001, improper levodopa formulation substitutions from 18.6% to 5%, p < 0.0001, timing deviations from 72.2% to 51.8%, p < 0.00001, missed doses from 21.5% to 16.8%, p = 0.013, and discharged to non-home settings from 44.8% to 38.3%, p = 0.038. Interpretation Following implementation of a multidisciplinary and proactive inpatient program, reductions in medication errors and improved discharge outcomes were observed among PwP. ANN NEUROL 2026;100:1068–1079

来源:Annals of Neurology,查看原文。版权归原作者所有。

引用

  1. Annals of Neurology:Effects of an Inpatient Program on Medication Errors in Hospitalized People with Parkinson's Disease

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。